cephalosporin c has been researched along with cefquinome in 97 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 9 (9.28) | 18.2507 |
2000's | 11 (11.34) | 29.6817 |
2010's | 63 (64.95) | 24.3611 |
2020's | 14 (14.43) | 2.80 |
Authors | Studies |
---|---|
Schimmel, D | 1 |
Isert, D; Klesel, N; Limbert, M; Markus, A; Schrinner, E; Seeger, K; Seibert, G | 1 |
Erwin, ME; Jones, RN; Murphy, SP | 1 |
Böttner, A; Humke, R; Schmid, P | 1 |
Böttner, A; Levin, D; Saran, A; Shpigel, NY; Winkler, M; Ziv, G | 1 |
Schmid, P; Shpigel, NY | 1 |
Hamel, U; Philipp, H; Quirke, JF; Schmidt, H | 1 |
Bataglia, J; Cañon, H; Hernández, P; Quiroz, A; San Martín, BN | 1 |
Hagn, J; Heinritzi, K | 1 |
Baş, AL; Birdane, FM; Elmas, M; Maden, M; Traş, B; Yazar, E | 1 |
Amiridis, GS; Dafopoulos, J; Fthenakis, GC; Mavrogianni, VS; Papanikolaou, T | 1 |
Thomas, E; Thomas, V; Wilhelm, C | 1 |
Ehinger, AM; Kietzmann, M; Schmidt, H | 1 |
Laven, RA | 1 |
Croubels, S; De Backer, P; Maes, A; Maes, D; Meyns, T; Sustronck, B | 1 |
Jiang, H; Li, J; Shen, J; Zhang, X | 1 |
Aarestrup, FM; Abatih, E; Cavaco, LM; Guardabassi, L | 1 |
Barker, SA; Paccamonti, DL; Parlevliet, JM | 1 |
Jiang, HY; Li, XB; Shen, JZ; Su, D; Wang, ZJ; Wu, WX | 1 |
Aarestrup, FM; Skov, RL | 1 |
Heckeroth, A; Leendertse, I; Rohdich, N; Thomas, E; Wilhelm, C; Zschiesche, E | 1 |
Eller, G; Klocke, D; Krömker, V; Paduch, JH; Reimann, A; Zinke, C | 1 |
Sobiraj, A; Sundrum, A; Werner, C | 1 |
Baptiste, KE; Friis, C; Winther, L | 1 |
Altan, F; Elmas, M; Uney, K | 1 |
Adriany, A; Meier, B; Schneider, E; Steffen, M; Thal, J; Usleber, E | 1 |
Fang, B; Liu, Y; Luo, X; Sun, J; Sun, L; Wang, R; Yuan, L; Zhu, L | 1 |
Bradley, AJ; Breen, JE; Green, MJ; Payne, B | 1 |
Barin, A; Bolourchi, M; Farzaneh, N; Gharagozlou, F; Hovareshti, P; Kasravi, R; Seifi, HA | 1 |
Hwang, YH; Kim, MS; Kim, TW; Lee, HK; Lim, JH; Park, BK; Song, IB; Yun, HI | 1 |
Cagnardi, P; Carli, S; Gallo, M; Locatelli, C; Moroni, P; Villa, R; Zonca, A | 1 |
Baptiste, KE; Damborg, P; Guardabassi, L; Marskar, P | 1 |
Gundelach, Y; Hamann, H; Hoedemaker, M; Kalscheuer, E | 1 |
Hagen, R; Muggli, E; Nuss, K; Schmid, B; Schmid, T | 1 |
Liu, B; Liu, Y; Sun, J; Yang, S; Yu, J; Zhang, C; Zhang, X | 1 |
Fink-Gremmels, J; Haritova, A; Heil, BA; Smiet, E; Wijnberg, ID | 1 |
Hwang, YH; Kim, MS; Kim, TW; Lee, HG; Lim, JH; Park, BK; Song, IB; Yun, HI | 1 |
Deng, H; Guo, JP; Liu, BT; Liu, YH; Liu, ZC; Yu, JJ; Zhang, CY; Zhang, Z; Zhao, DH | 1 |
Du, S; Wang, T; Xie, W; Zhang, X | 1 |
Balaje, R; Dinakaran, V; Dumka, VK; Ranjan, B; Sidhu, PK | 1 |
Bradley, AJ; Green, MJ; Lam, TJ; Swinkels, JM | 1 |
Cox, P; Lam, TJ; Schukken, YH; Swinkels, JM | 1 |
Biasi, G; Bonilauri, P; Dottori, M; Gherpelli, Y; Luppi, A; Maioli, G; Martelli, P; Merialdi, G | 1 |
Ding, H; He, L; Shan, Q; Wang, J; Yang, F; Zeng, Z | 1 |
Bailey-Horne, V; Brunton, L; Coldham, N; Heinrich, K; Horton, R; Jones, J; McLaren, I; Randall, L; Sharma, M; Sharman, M; Teale, C | 1 |
Ding, H; Gu, M; Gu, X; Li, X; Li, Y; Shen, X; Zhang, B; Zhang, N | 2 |
Bousquet-Mélou, A; Ferran, AA; Henri, J; Laurentie, M; Perrin-Guyomard, A; Rolland, JG; Toutain, PL; Vasseur, MV | 1 |
Ding, HZ; Gu, MX; Gu, XY; Li, XH; Lu, XX; Shen, XG; Zhang, BX; Zhang, N | 1 |
Ding, H; Liang, C; Shan, Q; Wang, J; Zeng, Z | 1 |
Barton, MD | 1 |
Bębenek, M; Dołhań, A; Jelińska, A | 1 |
Li, J; Liang, C; Shan, Q; Wang, J; Zeng, Z | 1 |
Krömker, V; Lam, TJ; Swinkels, JM | 1 |
Dumka, VK; Venkatachalam, D | 1 |
Bailey-Horne, V; Brunton, LA; Heinrich, K; Horton, RA; Jones, JR; La Ragione, RM; Randall, LP; Sharman, M | 1 |
Bai, Y; Liu, S; Ma, L; Shan, Q; Yin, Y; Zheng, G; Zhu, X | 1 |
Liu, YH; Peng, YB; Shi, W; Yang, X; Yu, Y; Zhao, DH; Zhou, YF | 1 |
Chen, Y; Huang, RJ; Huang, T; Liu, YH; Qiao, GG; Sun, J; Xiao, X; Zhou, YF | 1 |
Ding, H; Gu, M; Gu, X; Shen, X; Xiong, M; Yang, Y; Zhang, L; Zhang, N | 1 |
Abbas, SS; Amer, SM; Arafa, RM; Yehia, AM | 1 |
Cao, C; Lu, Y; Qiu, Z; Qu, Y; Sun, M; Zeng, Z; Zhang, Y; Zhong, J | 1 |
Guo, C; Liao, X; Liu, Y; Sun, J; Wang, F; Wang, M; Xiao, X; Yan, C | 1 |
Cao, Y; Jiang, SX; Liu, LF; Yang, Q; Yu, Q | 1 |
Chen, MR; Li, X; Liao, XP; Liu, YH; Qiao, GL; Sun, J; Yu, Y; Zhou, YF | 1 |
Shan, Q; Wang, J | 1 |
Assié, S; Bousquet-Mélou, A; Dupouy, V; El Garch, F; Lhermie, G; Ravinet, N; Seegers, H; Toutain, PL | 1 |
Dai, C; Guo, H; Hao, Z; Qu, S; Wang, C; Zhao, L; Zhu, J | 1 |
Cao, J; Dai, W; He, B; Lei, Z; Lu, Z; Yang, B; Zhang, S; Zhou, H | 1 |
Amer, MS; Dell'Anna, G; El-Nabtity, SM; Elazab, ST; Elsayed, MG; Ensley, SM; Griffith, RW; Hsu, WH; Mullin, K; Schrunk, DE | 1 |
De Vliegher, S; Piepers, S; Stevens, M; Supré, K | 1 |
Dai, C; Hao, Z; Huang, T; Li, Y; Qu, S; Xu, T; Yang, F; Zhao, L | 1 |
Dai, C; Hao, Z; Li, Y; Qu, S; Zhao, L; Zhu, J | 1 |
Bachmann, J; Bertulat, S; Helmschrodt, C; Heuwieser, W; Richter, A | 2 |
Li, H; Wang, C; Wang, L | 1 |
Bertulat, S; Finnah, A; Helmschrodt, C; Heuwieser, W; Klein, L; Richter, A; Schmidt, K | 1 |
Shantier, SW | 1 |
Corum, DD; Corum, O; Er, A; Uney, K | 1 |
Dai, C; Hao, Z; Huang, T; Qu, S; Tang, Q; Wang, H; Yang, F; Zhang, Y | 1 |
Bellanger, L; Fourmond, MP; Gaugain, M; Hurtaud-Pessel, D; Laurentie, M; Manceau, J; Mompelat, S; Rolland, JG; Verdon, E | 1 |
Amarante, AF; Guerra, ST; Latosinski, GS; Pantoja, JCF; Rall, VLM; Rossi, BF; Rossi, RS | 1 |
Amer, AMM; Constable, PD; El Badawy, SA; Eldeib, KM; Kamel, GM | 1 |
Chen, S; Dou, H; Fu, H; Li, D; Lin, J; Liu, Q; Peng, G; Shen, Y; Shu, G; Wu, W; Yin, L; Yuan, Z; Zhang, L; Zhang, W; Zhong, Z | 1 |
Adamopoulou, M; Christodoulopoulos, G; Filioussis, G; Grinberg, A; Hadjichristodoulou, C; Kachrimanidou, M; Kritas, SK; Kyritsi, M; Tzivara, A | 1 |
Damborg, P; Hartnack, S; Kirchgaessner, C; Moodley, A; Schmitt, S; Schoster, A; van Spijk, JN | 1 |
Al-Nazawi, M; Altayban, A; Kandeel, M; Kitade, Y | 1 |
Himelfarb, MA; Litterio, NJ; Lorenzutti, AM; San Andrés-Larrea, MI; Serrano-Rodríguez, JM; Zarazaga, MDP | 1 |
Chen, H; Cheng, F; Cheng, P; Feng, T; Fu, G; He, X; Li, X; Tian, L; Wu, J; Zeng, Y; Zhang, Y; Zheng, L | 1 |
Arpaillange, N; Bousquet-Mélou, A; Dupouy, V; Haenni, M; Madec, JY; Métayer, V; Roques, B; Wucher, J | 1 |
Baere, S; Croubels, S; Devreese, M; Rutjens, S | 1 |
Aqib, AI; Hao, H; Hussain, HI; Ihsan, A; Iqbal, Z; Kuang, X; Sattar, A; Seleem, MN; Shabbir, MAB | 1 |
Chen, Y; Gao, L; Yang, Y; Zhu, H | 1 |
Chen, W; Chen, X; Chen, Y; He, X; Liu, C; Ma, S; Mao, Y; Shen, Y; Wang, Y; Wu, Y; Yang, H; Zheng, Y | 1 |
Chen, L; Liu, X; Liu, Y; Lv, Q; Yang, Q; Yong, K; Zhang, C; Zhang, L; Zhang, Y; Zhong, P | 1 |
Croubels, S; Devreese, M; Rutjens, S; Sauer, J; Vereecke, N | 1 |
Cai, X; Hou, Y; Huang, L; Liu, Z; Ma, W; Mi, K; Pan, Y; Sun, L; Xu, X; Zhou, K | 1 |
2 review(s) available for cephalosporin c and cefquinome
Article | Year |
---|---|
[Contribution to the treatment of acute bovine mastitis with cefquinome].
Topics: Animals; Cattle; Cephalosporins; Clinical Trials as Topic; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Mastitis, Bovine; Multicenter Studies as Topic | 1997 |
Review on the Characteristic, Properties and Analytical Methods of Cefquinomesulphate: ß-lactam Veterinary Drug.
Topics: Animals; Anti-Bacterial Agents; Biological Availability; Cephalosporins; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Molecular Structure; Veterinary Drugs | 2020 |
21 trial(s) available for cephalosporin c and cefquinome
Article | Year |
---|---|
[Treatment of acute respiratory tract diseases in cattle with Bisolvon in combination with either enrofloxacin, cefquinome, ceftiofur or florfenicol].
Topics: Acute Disease; Administration, Oral; Animals; Anti-Infective Agents; Bromhexine; Cattle; Cattle Diseases; Cephalosporins; Drug Therapy, Combination; Enrofloxacin; Fluoroquinolones; Injections; Quinolones; Respiratory Tract Infections; Thiamphenicol | 1998 |
Use of cefquinome for prevention and treatment of bovine endometritis.
Topics: Animals; Cattle; Cattle Diseases; Cephalosporins; Endometritis; Escherichia coli Infections; Female; Injections, Intramuscular; Severity of Illness Index; Treatment Outcome | 2003 |
Efficacy of systemic cefquinome and erythromycin against digital dermatitis in cattle.
Topics: Administration, Cutaneous; Animals; Anti-Bacterial Agents; Baths; Cattle; Cattle Diseases; Cephalosporins; Erythromycin; Female; Foot Dermatoses; Injections, Intramuscular; Severity of Illness Index; Treatment Outcome | 2006 |
Evaluation of increased milking frequency as an additional treatment for cows with clinical mastitis.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cell Count; Cephalosporins; Dairying; Female; Lactation; Logistic Models; Mastitis, Bovine; Milk; Time Factors | 2010 |
Efficacy of homeopathic and antibiotic treatment strategies in cases of mild and moderate bovine clinical mastitis.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cephalosporins; Cloxacillin; Female; Mastitis, Bovine; Materia Medica | 2010 |
Pharmacokinetics and bioavailability of cefquinome in healthy ducks.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Biological Availability; Cephalosporins; Ducks; Female; Injections, Intramuscular; Injections, Intravenous; Male | 2011 |
Efficacy of conventional and extended intra-mammary treatment of persistent sub-clinical mastitis with cefquinome in lactating dairy cows.
Topics: Animals; Anti-Bacterial Agents; Asymptomatic Infections; Cattle; Cell Count; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Injections, Intradermal; Iran; Mammary Glands, Animal; Mastitis, Bovine; Staphylococcal Infections; Staphylococcus; Streptococcal Infections; Streptococcus; Time Factors | 2011 |
Pharmacokinetics and bioavailability of cefquinome in rabbits following intravenous and intramuscular administration.
Topics: Animals; Anti-Bacterial Agents; Biological Availability; Cephalosporins; Chromatography, Liquid; Cross-Over Studies; Half-Life; Injections, Intramuscular; Injections, Intravenous; Linear Models; Male; Rabbits | 2011 |
Pharmacokinetics and bioavailability of cefquinome in crossbred wild boars.
Topics: Animals; Anti-Bacterial Agents; Biological Availability; Cephalosporins; Cross-Over Studies; Female; Male; Sus scrofa | 2012 |
Influence of the injection site on the pharmacokinetics of cefquinome following intramuscular injection in piglets.
Topics: Analysis of Variance; Animals; Biological Availability; Cephalosporins; Chromatography, Liquid; Cross-Over Studies; Crosses, Genetic; Injections, Intramuscular; Mass Spectrometry; Neck; Sus scrofa; Thigh | 2013 |
Population pharmacokinetics of cefquinome in pigs.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Cephalosporins; Female; Half-Life; Injections, Intramuscular; Male; Nonlinear Dynamics; Reproducibility of Results; Swine | 2013 |
Efficacy of extended cefquinome treatment of clinical Staphylococcus aureus mastitis.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cell Count; Cephalosporins; Female; Mammary Glands, Animal; Mastitis, Bovine; Milk; Staphylococcal Infections; Treatment Outcome | 2013 |
Pharmacokinetics and ex-vivo pharmacodynamics of cefquinome against Klebsiella pneumonia in healthy dogs.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Biological Availability; Cephalosporins; Cross-Over Studies; Dogs; Half-Life; Injections, Intramuscular; Injections, Intravenous; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2014 |
Efficacy of standard vs. extended intramammary cefquinome treatment of clinical mastitis in cows with persistent high somatic cell counts.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cephalosporins; Drug Administration Schedule; Female; Mastitis, Bovine; Milk | 2014 |
In vivo activity of cefquinome against Riemerella anatipestifer using the pericarditis model in the duck.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Cephalosporins; Drug Administration Schedule; Ducks; Flavobacteriaceae Infections; Half-Life; Lethal Dose 50; Microbial Sensitivity Tests; Pericarditis; Poultry Diseases; Riemerella | 2016 |
Impact of Low and High Doses of Marbofloxacin on the Selection of Resistant Enterobacteriaceae in the Commensal Gut Flora of Young Cattle: Discussion of Data from 2 Study Populations.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cattle Diseases; Cephalosporins; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Feces; Fluoroquinolones; Gastrointestinal Microbiome; Gastrointestinal Tract; Male; Microbial Sensitivity Tests; Quinolones | 2017 |
Pharmacokinetics of cefquinome in healthy and Pasteurella multocida-infected rabbits.
Topics: Animals; Area Under Curve; Cephalosporins; Female; Half-Life; Pasteurella Infections; Pasteurella multocida; Rabbits | 2018 |
Pharmacokinetics of cefquinome after single and repeated subcutaneous administrations in sheep.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Bacteria; Cephalosporins; Drug Administration Schedule; Half-Life; Injections, Subcutaneous; Microbial Sensitivity Tests; Sheep | 2019 |
Efficacy of cefquinome and a combination of cloxacillin and ampicillin for treatment of dairy cows with Streptococcus agalactiae subclinical mastitis.
Topics: Ampicillin; Animals; Cattle; Cell Count; Cephalosporins; Cloxacillin; Dairying; Drug Therapy, Combination; Female; Mastitis, Bovine; Risk Factors; Streptococcus agalactiae; Treatment Outcome | 2019 |
Pharmacokinetics and pharmacodynamics of intramammary cefquinome in lactating goats with and without experimentally induced Staphylococcus aureus mastitis.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Female; Goat Diseases; Goats; Lactation; Mastitis; Milk; Staphylococcal Infections; Staphylococcus aureus | 2019 |
Comparative pharmacokinetics and pharmacokinetic/pharmacodynamic analysis by nonlinear mixed-effects modeling of cefquinome in nonpregnant, pregnant, and lactating goats after intravenous and intramuscular administration.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Cephalosporins; Computer Simulation; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Goats; Half-Life; Injections, Intramuscular; Injections, Intravenous; Lactation; Models, Biological; Pregnancy | 2021 |
74 other study(ies) available for cephalosporin c and cefquinome
Article | Year |
---|---|
[Possibilities for the establishment of pneumonia-free swine herds by immunization and administration of cefquinome].
Topics: Animals; Bacterial Vaccines; Bordetella bronchiseptica; Cephalosporins; Female; Immunization; Male; Pasteurella multocida; Pneumonia; Rhinitis, Atrophic; Swine; Swine Diseases | 1992 |
Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V), a new broad-spectrum cephalosporin.
Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Proteins; beta-Lactamases; Blood Proteins; Carrier Proteins; Cattle; Cephalosporins; Culture Media; Dogs; Enzyme Stability; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Hexosyltransferases; Horses; Hydrogen-Ion Concentration; Male; Mice; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Sepsis; Swine | 1991 |
Cefquinome (HR 111V). In vitro evaluation of a broad-spectrum cephalosporin indicated for infections in animals.
Topics: Animals; Bacterial Infections; Cephalosporins; Drug Resistance, Microbial; Evaluation Studies as Topic; Microbial Sensitivity Tests | 1994 |
In vitro efficacy of cefquinome (INN) and other anti-infective drugs against bovine bacterial isolates from Belgium, France, Germany, The Netherlands, and the United Kingdom.
Topics: Animals; Anti-Bacterial Agents; Belgium; Cattle; Cattle Diseases; Cephalosporins; Escherichia coli; France; Germany; Microbial Sensitivity Tests; Netherlands; Pasteurella; Salmonella; United States | 1995 |
Efficacy of cefquinome for treatment of cows with mastitis experimentally induced using Escherichia coli.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Injections, Intramuscular; Lactation; Mammary Glands, Animal; Mastitis, Bovine | 1997 |
Absorption and excretion of cefquinome in coho salmon (Oncorhynchus kisutch) in freshwater at 10 degrees C.
Topics: Animals; Brain; Cephalosporins; Cold Temperature; Fresh Water; Injections, Intraperitoneal; Kidney; Liver; Metabolic Clearance Rate; Muscle, Skeletal; Oncorhynchus kisutch; Tissue Distribution | 1998 |
[Effectiveness and disposition of the newly developed cephalosporin cefquinome in puerperal septicemia and toxemia in gilts].
Topics: Amoxicillin; Animals; Cephalosporins; Endometritis; Female; Microbial Sensitivity Tests; Puerperal Disorders; Sepsis; Swine; Swine Diseases; Syndrome; Toxemia | 1999 |
Investigation of biochemical and haematological side-effects of cefquinome in healthy dogs.
Topics: Animals; Biochemical Phenomena; Blood Gas Analysis; Cephalosporins; Dogs; Female; Hemodynamics; Injections, Intramuscular | 2001 |
Antibacterial activity of cefquinome against equine bacterial pathogens.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cephalosporins; Colony Count, Microbial; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Horse Diseases; Horses; Microbial Sensitivity Tests; Time Factors | 2006 |
Tissue distribution of cefquinome after intramammary and "systemic" administration in the isolated perfused bovine udder.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cephalosporins; Chromatography, High Pressure Liquid; Female; Infusions, Parenteral; Injections, Intramuscular; Lymph Nodes; Mammary Glands, Animal; Mastitis, Bovine; Perfusion; Tissue Distribution | 2006 |
Determination of cefquinome in pig plasma and bronchoalveolar lavage fluid by high-performance liquid chromatography combined with electrospray ionization mass spectrometry.
Topics: Animals; Anti-Infective Agents; Bronchoalveolar Lavage Fluid; Cephalosporins; Chromatography, Liquid; Spectrometry, Mass, Electrospray Ionization; Swine | 2007 |
Residue depletion of cefquinome in swine tissues after intramuscular administration.
Topics: Adipose Tissue; Animals; Anti-Bacterial Agents; Cephalosporins; Chromatography, High Pressure Liquid; Drug Residues; Injections, Intramuscular; Kidney; Liver; Muscles; Reproducibility of Results; Swine | 2007 |
Selection and persistence of CTX-M-producing Escherichia coli in the intestinal flora of pigs treated with amoxicillin, ceftiofur, or cefquinome.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Colony Count, Microbial; Escherichia coli; Female; Genes, Bacterial; Intestines; Mutation; Nalidixic Acid; Respiratory Tract Infections; Sus scrofa; Swine Diseases | 2008 |
Cefquinome concentrations in endometrium after intrauterine treatment of cobactan 4.5% in mares and inflammatory response of the endometrium to this treatment.
Topics: Animals; Anti-Bacterial Agents; Biopsy; Cephalosporins; Endometritis; Endometrium; Female; Horse Diseases; Horses; Uterus | 2009 |
Pharmacokinetics and bioavailability of cefquinome in healthy piglets.
Topics: Animals; Area Under Curve; Biological Availability; Cephalosporins; Chromatography, High Pressure Liquid; Female; Half-Life; Injections, Intramuscular; Injections, Intravenous; Male; Metabolic Clearance Rate; Swine | 2008 |
Evaluation of ceftiofur and cefquinome for phenotypic detection of methicillin resistance in Staphylococcus aureus using disk diffusion testing and MIC-determinations.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Disk Diffusion Antimicrobial Tests; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Phenotype; Sensitivity and Specificity; Staphylococcal Infections; Swine; Swine Diseases | 2010 |
Treatment of septicaemia and severe bacterial infections in foals with a new cefquinome formulation: a field study.
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Cephalosporins; Horse Diseases; Horses; Immunoglobulin G; Injections, Intramuscular; Injections, Intravenous; Random Allocation; Sepsis; Treatment Outcome | 2009 |
Antimicrobial disposition in pulmonary epithelial lining fluid of horses, part III. cefquinome.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Body Fluids; Cephalosporins; Half-Life; Horses; Lung; Respiratory Mucosa; Tissue Distribution | 2011 |
Development and validation of a high-performance liquid chromatography method for determination of cefquinome concentrations in sheep plasma and its application to pharmacokinetic studies.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Chromatography, High Pressure Liquid; Female; Freezing; Quality Control; Reference Standards; Sensitivity and Specificity; Sheep; Spectrophotometry, Ultraviolet; Temperature; Time Factors | 2011 |
Development of an enzyme immunoassay for the antibiotic cefquinome and its application for residue determination in cow's milk after therapeutical mastitis treatment.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cephalosporins; Female; Glucose Oxidase; Hemocyanins; Immunoenzyme Techniques; Mastitis, Bovine; Milk; Molecular Structure; Stereoisomerism | 2011 |
A comparison of broad-spectrum and narrow-spectrum dry cow therapy used alone and in combination with a teat sealant.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Cattle; Cell Count; Cephalosporins; Cloxacillin; Drug Therapy, Combination; Female; Lactation; Mammary Glands, Animal; Mastitis, Bovine; Milk; Postpartum Period; Random Allocation | 2011 |
Cefquinome sulfate behavior after intramammary administration in healthy and infected cows.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cephalosporins; Drug Administration Routes; Female; Lactation; Mammary Glands, Animal; Mastitis, Bovine; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus | 2011 |
Faecal shedding of CTX-M-producing Escherichia coli in horses receiving broad-spectrum antimicrobial prophylaxis after hospital admission.
Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactamases; Cefotaxime; Cephalosporins; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Proteins; Feces; Female; Horses; Longitudinal Studies; Male; Polymerase Chain Reaction | 2012 |
Risk factors associated with bacteriological cure, new infection, and incidence of clinical mastitis after dry cow therapy with three different antibiotics.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Cattle; Cephalosporins; Female; Framycetin; Germany; Incidence; Lactation; Mammary Glands, Animal; Mastitis, Bovine; Penicillins; Risk Factors | 2011 |
Diagnosis and treatment of lumbosacral discospondylitis in a calf.
Topics: Animals; Anti-Infective Agents; Cattle; Cattle Diseases; Cephalosporins; Discitis; Female; Lumbosacral Region; Radiography; Ultrasonography | 2011 |
Comparing the pharmacokinetics of a fourth generation cephalosporin in three different age groups of New Forest ponies.
Topics: Aging; Animals; Animals, Newborn; Anti-Bacterial Agents; Area Under Curve; Cephalosporins; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Female; Half-Life; Horses; Microbial Sensitivity Tests | 2012 |
Pharmacokinetic analysis of cefquinome in healthy chickens.
Topics: Administration, Intravenous; Animals; Anti-Bacterial Agents; Cephalosporins; Chickens; Injections, Intramuscular; Kinetics | 2013 |
Pharmacokinetics following intravenous administration and pharmacodynamics of cefquinome in buffalo calves.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Buffaloes; Cephalosporins; Chromatography, High Pressure Liquid; Escherichia coli; Half-Life; Injections, Intravenous; Kinetics; Limit of Detection; Male; Microbial Sensitivity Tests; Pasteurella multocida | 2013 |
Effect of extended cefquinome treatment on clinical persistence or recurrence of environmental clinical mastitis.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cephalosporins; Drug Administration Schedule; Female; Mastitis, Bovine; Recurrence | 2013 |
Antimicrobial resistance of F4+ Escherichia coli isolated from Swine in Italy.
Topics: Animals; Anti-Bacterial Agents; Antigens, Bacterial; Cephalosporins; Diarrhea; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Enrofloxacin; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Fimbriae Proteins; Fluoroquinolones; Italy; Swine; Swine Diseases; Thiamphenicol | 2015 |
Pharmacokinetic/pharmacodynamic relationship of cefquinome against Pasteurella multocida in a tissue-cage model in yellow cattle.
Topics: Animals; Area Under Curve; Cattle; Cephalosporins; Cross-Over Studies; Female; Half-Life; Injections, Intramuscular; Injections, Intravenous; Microbial Sensitivity Tests; Pasteurella Infections; Pasteurella multocida | 2014 |
Detection of antibiotic residues and association of cefquinome residues with the occurrence of Extended-Spectrum β-Lactamase (ESBL)-producing bacteria in waste milk samples from dairy farms in England and Wales in 2011.
Topics: Animals; beta-Lactamases; Cattle; Cephalosporins; DNA, Bacterial; England; Escherichia coli; Escherichia coli Infections; Feces; Female; Mastitis, Bovine; Microbial Sensitivity Tests; Milk; Polymerase Chain Reaction; Serotyping; Statistics, Nonparametric; Surveys and Questionnaires; Wales | 2014 |
Low or high doses of cefquinome targeting low or high bacterial inocula cure Klebsiella pneumoniae lung infections but differentially impact the levels of antibiotic resistance in fecal flora.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Cephalosporins; Drug Resistance, Bacterial; Feces; Klebsiella Infections; Klebsiella pneumoniae; Male; Pneumonia, Bacterial; Rats | 2014 |
Pharmacokinetics and ex vivo pharmacodynamics of cefquinome in porcine serum and tissue cage fluids.
Topics: Administration, Intravenous; Animals; Anti-Bacterial Agents; Cephalosporins; Chromatography, High Pressure Liquid; Diffusion Chambers, Culture; Escherichia coli; Female; Injections, Intramuscular; Male; Microbial Sensitivity Tests; Swine | 2014 |
Pharmacodynamics of cefquinome in a neutropenic mouse thigh model of Staphylococcus aureus infection.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Cephalosporins; Disease Models, Animal; Female; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Specific Pathogen-Free Organisms; Staphylococcal Infections; Staphylococcus aureus; Tandem Mass Spectrometry; Thigh | 2014 |
Impact of antibiotic use in the swine industry.
Topics: Animals; Anti-Bacterial Agents; Campylobacter; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Methicillin-Resistant Staphylococcus aureus; Salmonella; Swine | 2014 |
Stability of ceftiofur sodium and cefquinome sulphate in intravenous solutions.
Topics: Anti-Bacterial Agents; Cephalosporins; Drug Stability; Drug Storage; Isotonic Solutions; Pharmaceutical Solutions; Ringer's Solution; Temperature | 2014 |
In vivo activity of cefquinome against Escherichia coli in the thighs of neutropenic mice.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Chromatography, Liquid; Escherichia coli; Escherichia coli Infections; Female; Mice; Microbial Sensitivity Tests; Neutropenia; Tandem Mass Spectrometry; Thigh | 2014 |
In vivo evaluation of mutant selection window of cefquinome against Escherichia coli in piglet tissue-cage model.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Diffusion Chambers, Culture; Disease Models, Animal; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Microbial Sensitivity Tests; Mutation; Swine | 2014 |
Pharmacokinetic profile of cefquinome after oral subchronic flubendiamide exposure and in vitro plasma protein binding in buffalo calves.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Benzamides; Blood Proteins; Buffaloes; Cephalosporins; Injections, Intravenous; Insecticides; Male; Sulfones | 2015 |
Degradation of cefquinome in spiked milk as a model for bioremediation of dairy farm waste milk containing cephalosporin residues.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Biodegradation, Environmental; Cattle; Cephalosporins; Dairying; Escherichia coli; Fermentation; Hot Temperature; Milk; Models, Biological; Waste Products | 2015 |
Pharmacokinetics of cefquinome in tilapia (Oreochromis niloticus) after a single intramuscular or intraperitoneal administration.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Chromatography, High Pressure Liquid; Injections, Intramuscular; Injections, Intraperitoneal; Tilapia | 2015 |
Pharmacokinetics, bioavailability and PK/PD relationship of cefquinome for Escherichia coli in Beagle dogs.
Topics: Animals; Anti-Bacterial Agents; Biological Availability; Cephalosporins; Dog Diseases; Dogs; Escherichia coli; Escherichia coli Infections; Female; Injections, Intramuscular; Injections, Intravenous; Injections, Subcutaneous; Male; Microbial Sensitivity Tests | 2015 |
In vitro dynamic pharmacokinetic/pharmacodynamic(PK/PD) modeling and PK/PD cutoff of cefquinome against Haemophilus parasuis.
Topics: Anti-Bacterial Agents; Cephalosporins; Haemophilus parasuis; In Vitro Techniques; Microbial Sensitivity Tests; Monte Carlo Method | 2015 |
Response of a clinical Escherichia coli strain to repeated cefquinome exposure in a piglet tissue-cage model.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Diffusion Chambers, Culture; Dose-Response Relationship, Drug; Escherichia coli Infections; Male; Microbial Sensitivity Tests; Random Allocation; Swine; Swine Diseases | 2015 |
Ratio manipulating spectrophotometry versus chemometry as stability indicating methods for cefquinome sulfate determination.
Topics: Analysis of Variance; Cephalosporins; Dosage Forms; Least-Squares Analysis; Reference Standards; Reproducibility of Results; Spectrophotometry | 2016 |
In Vivo Pharmacodynamics of Cefquinome in a Neutropenic Mouse Thigh Model of Streptococcus suis Serotype 2 at Varied Initial Inoculum Sizes.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Streptococcal Infections; Streptococcus suis; Thigh | 2016 |
Enhancement of sodium taurocholate to the absorption of cefquinome.
Topics: Animals; Caco-2 Cells; Cell Survival; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Intestinal Absorption; Rats; Taurocholic Acid | 2016 |
In Vivo Pharmacokinetics/Pharmacodynamics of Cefquinome in an Experimental Mouse Model of Staphylococcus Aureus Mastitis following Intramammary Infusion.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Cattle; Cephalosporins; Disease Models, Animal; Female; Injections; Mastitis; Mice; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2016 |
Activity of cefquinome against extended-spectrum β-lactamase-producing Klebsiella pneumoniae in neutropenic mouse thigh model.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cattle; Cephalosporins; Drug Interactions; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Sheep; Swine; Tandem Mass Spectrometry | 2017 |
Preparation and testing of cefquinome-loaded poly lactic-co-glycolic acid microspheres for lung targeting.
Topics: Animals; Cephalosporins; Glycols; Lactic Acid; Lung; Microspheres; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2017 |
Preparation and evaluation of cefquinome-loaded gelatin microspheres and the pharmacokinetics in pigs.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Delayed-Action Preparations; Gelatin; Microspheres; Swine | 2018 |
Antimicrobial consumption on dairy herds and its association with antimicrobial inhibition zone diameters of non-aureus staphylococci and Staphylococcus aureus isolated from subclinical mastitis.
Topics: Animals; Anti-Infective Agents; Cattle; Cephalosporins; Female; Humans; Mastitis, Bovine; Milk; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus | 2018 |
A Comparison of Two Methods for the Preparation Cefquinome-Loaded Gelatin Microspheres for Lung Targeting.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Chemistry, Pharmaceutical; Cross-Linking Reagents; Delayed-Action Preparations; Drug Compounding; Drug Liberation; Female; Gelatin; Injections, Intravenous; Lung; Lung Diseases; Male; Microspheres; Particle Size; Pharmaceutical Vehicles; Rats; Rats, Wistar; Tissue Distribution; Veterinary Drugs | 2018 |
Cefquinome-loaded microsphere formulations against Klebsiella pneumonia infection during experimental infections.
Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Cephalosporins; Disease Models, Animal; Drug Carriers; Drug Compounding; Drug Liberation; Host-Pathogen Interactions; Inflammation Mediators; Interleukin-1beta; Interleukin-8; Klebsiella Infections; Klebsiella pneumoniae; Lung; Male; Microspheres; Particle Size; Pneumonia, Bacterial; Polyesters; Rats, Wistar; Surface Properties; Technology, Pharmaceutical; Time Factors; Tumor Necrosis Factor-alpha | 2018 |
Residue concentration of cefquinome after intramammary dry cow therapy and short dry periods.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cephalosporins; Drug Residues; Female; Lactation; Mammary Glands, Animal; Milk; Pregnancy | 2018 |
Selection of DNA aptamers and establishment of an effective aptasensor for highly sensitive detection of cefquinome residues in milk.
Topics: Animals; Aptamers, Nucleotide; Biosensing Techniques; Cattle; Cephalosporins; Drug Residues; Food Contamination; Limit of Detection; Milk; SELEX Aptamer Technique | 2018 |
Quantitative analysis of cefquinome considering different matrix compositions of bovine colostrum and raw milk.
Topics: Animals; Cattle; Cephalosporins; Chromatography, Liquid; Colostrum; Milk; Reproducibility of Results; Sensitivity and Specificity; Specimen Handling; Tandem Mass Spectrometry; Time Factors | 2018 |
Cefquinome-Loaded Microsphere Formulations in Protection against Pneumonia with Klebsiella pneumonia Infection and Inflammatory Response in Rats.
Topics: Animals; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Cephalosporins; Cytokines; Disease Models, Animal; Drug Carriers; Drug Compounding; Drug Delivery Systems; Inflammation; Injections, Intravenous; Klebsiella Infections; Klebsiella pneumoniae; Male; Microspheres; Pneumonia, Bacterial; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Wistar | 2019 |
A non-targeted LC-HRMS approach for detecting exposure to illegal veterinary treatments: The case of cephalosporins in commercial laying Hens.
Topics: Animals; Biomarkers; Cephalosporins; Chickens; Chromatography, Liquid; Feces; Female; France; Humans; Illicit Drugs; Liver; Mass Spectrometry; Models, Statistical; Ovum; Substance Abuse Detection; Veterinary Drugs | 2019 |
Preparation of cefquinome sulfate cationic proliposome and evaluation of its efficacy on Staphylococcus aureus biofilm.
Topics: Anti-Bacterial Agents; Biofilms; Cations; Cephalosporins; Cholesterol; Drug Compounding; Drug Liberation; Kinetics; Liposomes; Microbial Sensitivity Tests; Phosphatidylcholines; Staphylococcus aureus | 2019 |
Residue concentration of cefquinome taking into account different milk fractions and comparing the performance of two screening tests.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cephalosporins; Chromatography, High Pressure Liquid; Colostrum; Drug Residues; False Positive Reactions; Female; Mastitis, Bovine; Milk; Postpartum Period; Tandem Mass Spectrometry | 2019 |
Short communication: Bovine mastitis caused by a multidrug-resistant, mcr-1-positive (colistin-resistant), extended-spectrum β-lactamase-producing Escherichia coli clone on a Greek dairy farm.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cattle; Cephalosporins; Colistin; Dairying; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Farms; Female; Greece; Mastitis, Bovine; Microbial Sensitivity Tests; Milk; Multilocus Sequence Typing | 2020 |
The effect of different antimicrobial treatment regimens on the faecal shedding of ESBL-producing Escherichia coli in horses.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Stewardship; Bacterial Shedding; beta-Lactamases; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Feces; Female; Gentamicins; Horse Diseases; Horses; Male; Penicillins; Prevalence | 2020 |
A pilot study on the pharmacokinetics of a single intramuscular injection of cefquinome in Arabian camel calves.
Topics: Animals; Anti-Bacterial Agents; Camelus; Cephalosporins; Injections, Intramuscular; Male; Pilot Projects | 2020 |
Comparative pharmacokinetics of intravenous and intramuscular cefquinome sulfate administration in ducklings and goslings.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Biological Availability; Cephalosporins; Ducks; Geese; Half-Life; Injections, Intramuscular; Injections, Intravenous; Sulfates | 2020 |
Selection of ESBL-producing Escherichia coli in the gut of calves experimentally fed with milk containing antibiotic residues.
Topics: Age Factors; Animal Feed; Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamases; Cattle; Cephalosporins; Escherichia coli; Escherichia coli Infections; Feces; Female; Gastrointestinal Microbiome; Genetic Variation; Male; Milk | 2021 |
Development and Validation of Liquid Chromatography-Tandem Mass Spectrometry Methods for the Quantification of Cefquinome, Ceftiofur, and Desfuroylceftiofuracetamide in Porcine Feces with Emphasis on Analyte Stability.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Calibration; Cephalosporins; Chromatography, High Pressure Liquid; Feces; Female; Furans; Injections, Intramuscular; Male; Observer Variation; Reproducibility of Results; Swine; Tandem Mass Spectrometry; Tazobactam | 2021 |
RNA-seq-based transcriptome analysis of a cefquinome-treated, highly resistant, and virulent MRSA strain.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Cephalosporins; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; RNA-Seq; Staphylococcal Infections | 2021 |
Antibacterial pathway of cefquinome against Staphylococcus aureus based on label-free quantitative proteomics analysis.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cephalosporin Resistance; Cephalosporins; Gene Ontology; Microbial Sensitivity Tests; Proteomics; Real-Time Polymerase Chain Reaction; Staphylococcus aureus | 2021 |
Cefquinome Sulfate Oily Nanosuspension Designed for Improving its Bioavailability in the Treatment of Veterinary Infections.
Topics: Animals; Anti-Bacterial Agents; Biological Availability; Cephalosporins; Nanoparticles; Particle Size; Rats; Solubility; Sulfates; Suspensions | 2022 |
The pharmacokinetics and pharmacodynamics of cefquinome against Streptococcus agalactiae in a murine mastitis model.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Female; Humans; Mastitis; Mice; Microbial Sensitivity Tests; Streptococcus agalactiae | 2023 |
Cefquinome shows a higher impact on the pig gut microbiome and resistome compared to ceftiofur.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Escherichia coli; Feces; Gastrointestinal Microbiome; RNA, Ribosomal, 16S; Swine | 2023 |
A physiologically based pharmacokinetic model to optimize the dosage regimen and withdrawal time of cefquinome in pigs.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Kidney; Liver; Respiratory Tract Infections; Swine | 2023 |